In April 2016 Manchester eScholar was replaced by the University of Manchester’s new Research Information Management System, Pure. In the autumn the University’s research outputs will be available to search and browse via a new Research Portal. Until then the University’s full publication record can be accessed via a temporary portal and the old eScholar content is available to search and browse via this archive.

Application of the dorsal window chamber to tumour vasculature manipulation studies.

Telfer, Brian

[Thesis]. Manchester, UK: The University of Manchester; 2012.

Access to files

Abstract

Developing and applying pre-clinical tumour models in order to determine the mechanistic action of applied therapies is essential if we aim to improve antitumour strategies in the clinical setting. The chaotic nature of tumour vasculature impacts directly on the effectiveness of combined chemo-radiotherapy and antiangiogenic (AA) strategies and as such warrants closer study. This work looked at the effects of novel AAs combined with clinically relevant radiotherapy (RT) using both conventional murine xenograft growth delay studies and real-time imaging. The imaging methodology was the non-invasive Dorsal Window Chamber/Intra Vital Microscopy (DWC/IVM) model which allows the study of real-time vascular responses to these therapies. The DWC/IVM model was applied to determine whether the DNA repair inhibitors Nicotinamide, AG14361 and AGO14699 had additional modes of action which could contribute to tumour radioresistance/radiosensitivity. Using the DWC/IVM model a secondary quantifiable mechanistic function was determined where these drugs also increased tumour vessel permeability. The DWC/IVM model was also used to investigate the effects of AZD2171 and AZD6244 combined with radiotherapy. These agents can inhibit angiogenic signalling pathways and it was demonstrated that both drugs worked by reducing tumour microvascular density when used in combination with radiation. In studies looking at the influence of hypoxia inducible factor-1(HIF-1) on tumour response to radiation the DWC/IVM model provided measurable differences in the microvascular density between HIF-1 deficient and HIF-1 competent tumours. The DWC/IVM model allowed the direct visualisation and quantification of the less well developed vasculature in HIF-1 deficient tumours compared to that found in HIF-1 competent tumours. The results provide a mechanistic basis for understanding the improved response to radiotherapy of HIF-1 deficient tumours.By applying the DWC/IVM model to conventional murine xenograft models the DWC/IVM proved itself as a useful research tool where continuous real-time non-invasive measurements could be made without the need for large numbers of time points or laborious histological analysis.

Bibliographic metadata

Type of resource:
Content type:
Form of thesis:
Type of submission:
Degree type:
Doctor of Philosophy
Degree programme:
PhD Pharmacy
Publication date:
Location:
Manchester, UK
Total pages:
203
Abstract:
Developing and applying pre-clinical tumour models in order to determine the mechanistic action of applied therapies is essential if we aim to improve antitumour strategies in the clinical setting. The chaotic nature of tumour vasculature impacts directly on the effectiveness of combined chemo-radiotherapy and antiangiogenic (AA) strategies and as such warrants closer study. This work looked at the effects of novel AAs combined with clinically relevant radiotherapy (RT) using both conventional murine xenograft growth delay studies and real-time imaging. The imaging methodology was the non-invasive Dorsal Window Chamber/Intra Vital Microscopy (DWC/IVM) model which allows the study of real-time vascular responses to these therapies. The DWC/IVM model was applied to determine whether the DNA repair inhibitors Nicotinamide, AG14361 and AGO14699 had additional modes of action which could contribute to tumour radioresistance/radiosensitivity. Using the DWC/IVM model a secondary quantifiable mechanistic function was determined where these drugs also increased tumour vessel permeability. The DWC/IVM model was also used to investigate the effects of AZD2171 and AZD6244 combined with radiotherapy. These agents can inhibit angiogenic signalling pathways and it was demonstrated that both drugs worked by reducing tumour microvascular density when used in combination with radiation. In studies looking at the influence of hypoxia inducible factor-1(HIF-1) on tumour response to radiation the DWC/IVM model provided measurable differences in the microvascular density between HIF-1 deficient and HIF-1 competent tumours. The DWC/IVM model allowed the direct visualisation and quantification of the less well developed vasculature in HIF-1 deficient tumours compared to that found in HIF-1 competent tumours. The results provide a mechanistic basis for understanding the improved response to radiotherapy of HIF-1 deficient tumours.By applying the DWC/IVM model to conventional murine xenograft models the DWC/IVM proved itself as a useful research tool where continuous real-time non-invasive measurements could be made without the need for large numbers of time points or laborious histological analysis.
Thesis main supervisor(s):
Thesis co-supervisor(s):
Thesis advisor(s):
Language:
en

Institutional metadata

University researcher(s):

Record metadata

Manchester eScholar ID:
uk-ac-man-scw:156044
Created by:
Telfer, Brian
Created:
17th February, 2012, 10:32:27
Last modified by:
Telfer, Brian
Last modified:
16th March, 2012, 11:36:51

Can we help?

The library chat service will be available from 11am-3pm Monday to Friday (excluding Bank Holidays). You can also email your enquiry to us.